Else Marit Inderberg leads a research unit performing immunomonitoring in clinical trials and development of cellular therapy at the Dept. of Cellular therapy, Oslo University Hospital. Her main research focus is on T-cell function and therapy development as well as the identification of predictive biomarkers of therapy response. She has broad oncology-related clinical trial experience and holds an MSc equivalent degree in Immunology from France and a PhD in tumour immunology from the University of Oslo, Norway. She has co-authored numerous peer-reviewed publications, holds several patents, and is co-founder of two separate spin-off companies.